Clinical Trial Update: Salvage Immunotherapy and Chemotherapy in Esophageal Squamous Cell Carcinoma Patients Nonresponding to Initial Neoadjuvant Chemoradiotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating salvage immunotherapy and chemotherapy in esophageal squamous cell carcinoma patients who did not respond to initial neoadjuva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Esophageal Squamous Cell Carcinomas | Phase 2 | Status: UNKNOWN